tradingkey.logo

Rectify And Boehringer Ingelheim Collaborate To Advance First-In-Class Treatments For Chronic Kidney Disease

ReutersDec 22, 2025 1:16 PM

-

  • RECTIFY AND BOEHRINGER INGELHEIM COLLABORATE TO ADVANCE FIRST-IN-CLASS TREATMENTS FOR CHRONIC KIDNEY DISEASE

  • RECITIFY: WILL RECEIVE UPFRONT PAYMENT, POTENTIAL TO EARN UP TO $448 MILLION THROUGH MILESTONES & ROYALTIES

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI